07
Jan 2020
New two-pronged attack beating ‘incurable’ blood cancer offers new hope for lymphocytic leukaemia patients
A new ‘two-pronged-attack’ combination drug therapy could provide a lifeline to thousands of patients in the UK battling incurable blood cancer. Until now, patients with chronic lymphocytic leukaemia, also known as CLL, one of the most common types of blood cancer in adults, have been forced to endure repeated rounds of gruelling chemotherapy to keep…
